11 results on '"Rodriguez-Valero N"'
Search Results
2. Corrigendum to “Host biomarkers for early identification of severe imported Plasmodium falciparum malaria” [Trav. Med. Infect. Dis. 54 (2023) 102608]
- Author
-
Balerdi-Sarasola, L., Parolo, C., Fleitas, P., Cruz, A., Subirà, C., Rodríguez-Valero, N., Almuedo-Riera, A., Letona, L., Álvarez-Martínez, M.J., Valls, M Eugenia, Vera, I., Mayor, A., Muñoz, J., and Camprubí-Ferrer, D.
- Published
- 2024
- Full Text
- View/download PDF
3. Causes of fever in returning travelers: a European multicenter prospective cohort study
- Author
-
Camprubi-Ferrer D, Cobuccio L, Van den Broucke S, Genton B, Bottieau E, D'Acremont V, Rodriguez-Valero N, Almuedo-Riera A, Balerdi-Sarasola L, Subira C, Fernandez-Pardos M, Martinez M, Navero-Castillejos J, Vera I, Llenas-Garcia J, Rothe C, Cadar D, Van Esbroeck M, Foque N, and Munoz J
- Abstract
Background Etiological diagnosis of febrile illnesses in returning travelers is a great challenge, particularly when presenting with no focal symptoms [acute undifferentiated febrile illnesses (AUFI)], but is crucial to guide clinical decisions and public health policies. In this study, we describe the frequencies and predictors of the main causes of fever in travelers. Methods Prospective European multicenter cohort study of febrile international travelers (November 2017-November 2019). A predefined diagnostic algorithm was used ensuring a systematic evaluation of all participants. After ruling out malaria, PCRs and serologies for dengue, chikungunya and Zika viruses were performed in all patients presenting with AUFI
- Published
- 2022
4. Prospective comparative multi-centre study on imported Plasmodium ovale wallikeri and Plasmodium ovale curtisi infections
- Author
-
Rojo-Marcos, G., Rubio-Munoz, J. M., Angheben, A., Jaureguiberry, S., Garcia-Bujalance, S., Tomasoni, L. R., Rodriguez-Valero, N., Ruiz-Giardin, J. M., Salas-Coronas, J., Cuadros-Gonzalez, J., Garcia-Rodriguez, M., Molina-Romero, I., Lopez-Velez, R., Gobbi, F., Calderon-Moreno, M., Martin-Echevarria, E., Elia-Lopez, M., Llovo-Taboada, J., Lago-Nunez, M., Castelli, F., Jaquetti, J., Alonso, C., Camprubi, D., Gorgolas-Hernandez-Mora, M., Cuevas-Tascon, G., Perez-Ayala, A., Guzman-Garciamonge, M. T., Ribell-Bachs, M., Serre-Delcor, N., Martin-Martin, Y., Ramirez-Olivencia, G., Cogollos-Agruna, R., Merino-Fernandez, F. J., Garcia-Castro, A., Cantudo-Munoz, P., Belhassen-Garcia, M., Martin-Rabadan, P., Rubio-Cuevas, P., Trigo-Esteban, E., and Arevalo-Serrano, J.
- Subjects
0301 basic medicine ,Male ,Plasmodium ovale ,Plasmodium ovale curtisi ,Gastroenterology ,chemistry.chemical_compound ,0302 clinical medicine ,Diabetes mellitus ,Communicable Diseases, Imported ,Epidemiology ,Prevalence ,Prospective Studies ,Antimalarials ,Comparative study ,INR ,Plasmodium ovale wallikeri ,Thrombocytopenia ,Adult ,Africa ,Europe ,Female ,Genotype ,Humans ,Incidence ,Malaria ,Middle Aged ,Sex Factors ,Species Specificity ,Young Adult ,Rapid diagnostic test ,biology ,digestive, oral, and skin physiology ,Infectious Diseases ,Chemoprophylaxis ,medicine.medical_specialty ,lcsh:Arctic medicine. Tropical medicine ,lcsh:RC955-962 ,030231 tropical medicine ,Communicable Diseases ,digestive system ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,stomatognathic system ,Internal medicine ,parasitic diseases ,medicine ,lcsh:RC109-216 ,Risk factor ,business.industry ,Research ,medicine.disease ,biology.organism_classification ,030104 developmental biology ,Imported ,chemistry ,Parasitology ,Artesunate ,business - Abstract
BACKGROUND: Few previous retrospective studies suggest that Plasmodium ovale wallikeri seems to have a longer latency period and produces deeper thrombocytopaenia than Plasmodium ovale curtisi. Prospective studies were warranted to better assess interspecies differences. METHODS: Patients with imported P. ovale spp. infection diagnosed by thick or thin film, rapid diagnostic test (RDT) or polymerase chain reaction (PCR) were recruited between March 2014 and May 2017. All were confirmed by DNA isolation and classified as P. o. curtisi or P. o. wallikeri using partial sequencing of the ssrRNA gene. Epidemiological, analytical and clinical differences were analysed by statistical methods. RESULTS: A total of 79 samples (35 P. o. curtisi and 44 P. o. wallikeri) were correctly genotyped. Males predominate in wallikeri group (72.7%), whereas were 48.6% in curtisi group. Conversely, 74.3% of curtisi group were from patients of African ethnicity, whilst 52.3% of Caucasians were infected by P. o. wallikeri. After performing a multivariate analysis, more thrombocytopaenic patients (p = 0.022), a lower number of platelets (p = 0.015), a higher INR value (p = 0.041), and shorter latency in Caucasians (p = 0.034) were significantly seen in P. o. wallikeri. RDT sensitivity was 26.1% in P. o. curtisi and 42.4% in P. o. wallikeri. Nearly 20% of both species were diagnosed only by PCR. Total bilirubin over 3 mg/dL was found in three wallikeri cases. Two patients with curtisi infection had haemoglobin under 7 g/dL, one of them also with icterus. A wallikeri patient suffered from haemophagocytosis. Chemoprophylaxis failed in 14.8% and 35% of curtisi and wallikeri patients, respectively. All treated patients with various anti-malarials which included artesunate recovered. Diabetes mellitus was described in 5 patients (6.32%), 4 patients of wallikeri group and 1 curtisi. CONCLUSIONS: Imported P. o. wallikeri infection may be more frequent in males and Caucasians. Malaria caused by P. o. wallikeri produces more thrombocytopaenia, a higher INR and shorter latency in Caucasians and suggests a more pathogenic species. Severe cases can be seen in both species. Chemoprophylaxis seems less effective in P. ovale spp. infection than in P. falciparum, but any anti-malarial drug is effective as initial treatment. Diabetes mellitus could be a risk factor for P. ovale spp. infection. This study has been funded with a grant FIB-PI14-04 from the Foundation for Biomedical Research of the Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain. Sí
- Published
- 2018
5. TRIP (Travel Remote Infomation Platform) - a platform for monitoring traveler's health
- Author
-
Rodriguez-Valero, N., María J. Ledesma-Carbayo, Cuadrado Sanchez, D., Vladimorov, A., Vera, I., Roldan, M., Alba, T., Sanz, S., Luengo Oroz, M., and Munoz, J.
- Subjects
Telecomunicaciones ,Medicina ,Electrónica ,human activities - Abstract
Most of the studies reporting symptoms during the travel are done retrospectively (1),(2), increasing the odds of recall bias. Moreover, there is no information about the percentage of travelers that suffer mild or no symptoms during their trips because they never attend to a clinic afterwards. A IM The main aim of the study is to detect incidence of symptoms real-time amongst travelers visiting tropical and subtropical countries. Also, comparing symptoms between travelers taking or not malaria chemoprophylaxis and other demographic variables.
- Published
- 2017
6. Not all severe malaria cases are severe: Is it time to redefine severity criteria for malaria in non-endemic regions?
- Author
-
Balerdi-Sarasola L, Muñoz J, Fleitas P, Rodriguez-Valero N, Almuedo-Riera A, Antequera A, Subirà C, Grafia-Perez I, Ortiz-Fernández M, de Alba T, Álvarez-Martínez MJ, Valls ME, Parolo C, Castro P, and Camprubí-Ferrer D
- Subjects
- Humans, Male, Female, Adult, Middle Aged, Cohort Studies, Adolescent, Child, Preschool, Child, Parasitemia epidemiology, Young Adult, Coinfection epidemiology, Aged, Infant, Malaria epidemiology, Malaria diagnosis, Malaria complications, Severity of Illness Index
- Abstract
Background: The current definition of severe malaria in non-endemic areas follows WHO criteria, which mainly target children in malaria-endemic areas, potentially misclassifying cases in non-endemic regions. We assessed the performance of a modified severe malaria classification criteria within our patient cohort., Methods: A cohort study of patients managed for malaria in a non-endemic setting (2005-2023) was analyzed. We classified patients into severe malaria (SM) using WHO 2013 criteria except for hyperparasitemia, where 2 % threshold was applied. Patients with SM were distinguished as very severe malaria (VSM) when presenting at least one of the following conditions: parasitemia >10 %, pulmonary edema, impaired consciousness, seizures, renal failure, metabolic acidosis or hyperlactatemia, shock or hypoglycemia. In patients with SM and no criteria for VSM, less severe malaria (LSM) was defined by: 2-10 % parasitemia, hyperbilirubinemia, prostration, anemia or minor bleeding. The primary composite outcome was death or the need for a life-saving intervention, as analyzed in the three comparative groups. Secondary outcome was the prevalence of co-infections., Results: Among 506 patients with malaria, 176 (34.8 %) presented with SM. A total of 37 (7.3 %) patients developed a life-threatening condition, namely death (n = 4) and/or the need for life-saving interventions (n = 34). All fatalities and 33 out of the 34 life-saving interventions occurred in the VSM group. Patients in LSM group did not develop any life-threatening conditions. As to co-infections, 28 (5.5 %) patients had a community-acquired co-infection, with no differences between groups (p = 0.763)., Conclusions: Severity criteria definitions would benefit from a review when assessing patients with malaria in non-endemic areas. Within the spectrum of SM, patients reclassified as LSM have a low risk of developing a life-threatening condition and present low co-infection incidence and could benefit from management out of intensive care units and a restrictive use of empirical antibiotics., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
7. Scalp myiasis presenting as forehead edema in a returning traveller from Belize: A diagnostic challenge.
- Author
-
Martínez-Lacalzada M, Vera I, Álvarez-Martínez MJ, Aylagas C, and Rodriguez-Valero N
- Subjects
- Animals, Humans, Belize, Scalp, Forehead, Edema, Larva, Travel, Myiasis diagnosis, Diptera
- Abstract
Competing Interests: Declaration of competing interest The authors have no conflicts of interest to declare.
- Published
- 2024
- Full Text
- View/download PDF
8. Characterization of Latin American migrants at risk for Trypanosoma cruzi infection in a non-endemic setting. Insights into initial evaluation of cardiac and digestive involvement.
- Author
-
Laynez-Roldán P, Losada-Galván I, Posada E, de la Torre Ávila L, Casellas A, Sanz S, Subirà C, Rodriguez-Valero N, Camprubí-Ferrer D, Vera I, Roldán M, Aldasoro E, Oliveira-Souto I, Calvo-Cano A, Valls ME, Álvarez-Martínez MJ, Gállego M, Abras A, Ballart C, Muñoz J, Gascón J, and Pinazo MJ
- Subjects
- Humans, Female, Male, Latin America epidemiology, Heart, Transients and Migrants, Chagas Disease diagnosis, Trypanosoma cruzi
- Abstract
Background: Trypanosoma cruzi causes Chagas disease (CD), a potentially fatal disease characterized by cardiac disorders and digestive, neurological or mixed alterations. T. cruzi is transmitted to humans by the bite of triatomine vectors; both the parasite and disease are endemic in Latin America and the United States. In the last decades, population migration has changed the classic epidemiology of T. cruzi, contributing to its global spread to traditionally non-endemic countries. Screening is recommended for Latin American populations residing in non-endemic countries., Methods: The present study analyzes the epidemiological characteristics of 2,820 Latin American individuals who attended the International Health Service (IHS) of the Hospital Clinic de Barcelona between 2002 and 2019. The initial assessment of organ damage among positive cases of T. cruzi infection was analyzed, including the results of electrocardiogram (ECG), echocardiogram, barium enema and esophagogram., Results: Among all the screened individuals attending the clinic, 2,441 (86.6%) were born in Bolivia and 1,993 (70.7%) were female. Of individuals, 1,517 (81.5%) reported previous exposure to the vector, which is a strong risk factor associated with T. cruzi infection; 1,382 individuals were positive for T. cruzi infection. The first evaluation of individuals with confirmed T. cruzi infection, showed 148 (17.1%) individuals with Chagasic cardiomyopathy, the main diagnostic method being an ECG and the right bundle branch block (RBBB) for the most frequent disorder; 16 (10.8%) individuals had a normal ECG and were diagnosed of Chagasic cardiomyopathy by echocardiogram., Conclusions: We still observe many Latin American individuals who were at risk of T. cruzi infection in highly endemic areas in their countries of origin, and who have not been previously tested for T. cruzi infection. In fact, even in Spain, a country with one of the highest proportion of diagnosis of Latin American populations, T. cruzi infection remains underdiagnosed. The screening of Latin American populations presenting with a similar profile as reported here should be promoted. ECG is considered necessary to assess Chagasic cardiomyopathy in positive individuals, but echocardiograms should also be considered as a diagnostic approach given that it can detect cardiac abnormalities when the ECG is normal., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2023 Laynez-Roldán et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
9. Positive direct antiglobulin test in post-artesunate delayed haemolysis: more than a coincidence?
- Author
-
Camprubí D, Pereira A, Rodriguez-Valero N, Almuedo A, Varo R, Casals-Pascual C, Bassat Q, Malvy D, and Muñoz J
- Subjects
- Administration, Intravenous adverse effects, Adolescent, Adult, Anemia, Hemolytic chemically induced, Coombs Test statistics & numerical data, Female, Humans, Male, Middle Aged, Retrospective Studies, Spain, Anemia, Hemolytic drug therapy, Antimalarials administration & dosage, Artesunate administration & dosage, Hemolysis drug effects, Malaria drug therapy
- Abstract
Background: Delayed haemolysis is a frequent adverse event after treatment with artesunate (AS). Removing once-infected "pitted" erythrocytes by the spleen is the most accepted mechanism of haemolysis in these cases. However, an increasing number of cases with positive direct antiglobulin test (DAT) haemolysis after AS have been reported., Methods: All malaria cases seen at Hospital Clinic of Barcelona between 2015 and 2017 were retrospectively reviewed. Clinical, parasitological and laboratory data from patients treated with intravenous artesunate-specifically looking for delayed haemolysis and DAT-was collected., Results: Among the 36 severe malaria patients treated with artesunate at the hospital, 10 (27.8%) developed post-artesunate delayed haemolysis. Out of these, DAT was performed in six, being positive in four of them (at least 40%). DAT was positive only for complement-without IgG-suggesting drug-dependent immune-haemolytic anaemia of the immune-complex type. Three of the four patients were treated with corticosteroids and two also received blood transfusion, with a complete recovery., Conclusions: Drug-induced auto-immune phenomena in post-artesunate delayed haemolysis may be underreported and must be considered. The role of corticosteroids should be reassessed.
- Published
- 2019
- Full Text
- View/download PDF
10. Mobile based surveillance platform for detecting Zika virus among Spanish Delegates attending the Rio de Janeiro Olympic Games.
- Author
-
Rodriguez-Valero N, Luengo Oroz M, Cuadrado Sanchez D, Vladimirov A, Espriu M, Vera I, Sanz S, Gonzalez Moreno JL, Muñoz J, and Ledesma Carbayo MJ
- Subjects
- Brazil, Female, Humans, Incidence, Internet, Male, Population Surveillance, Spain, Tropical Medicine, Disease Outbreaks, Travel, Travel-Related Illness, Zika Virus, Zika Virus Infection epidemiology, Zika Virus Infection virology
- Abstract
Background: Zika virus has created a major epidemic in Central and South America, especially in Brazil, during 2015-16. The infection is strongly associated with fetal malformations, mainly microcephaly, and neurological symptoms in adults. During the preparation of the Rio de Janeiro Olympic Games in 2016, members of Olympic Delegations worldwide expressed their concern about the health consequences of being infected with Zika virus. A major risk highlighted by the scientific community was the impact on the spreading of the virus into new territories immediately after the Games., Objectives: To detect real-time incidence of symptoms compatible with arboviral diseases and other tropical imported diseases among the Spanish Olympic Delegation (SOD) attending the Rio Olympic Games in 2016., Methods: We developed a surveillance platform based on a mobile application installed in participant's smartphones that monitored the health status of the SOD through a daily interactive check of the user health status including geo-localization data. The results were evaluated by a study physician on-call through a web-based platform monitoring system. Participants presenting severe symptoms or those compatible with Zika infection prompted an alarm in the system triggering specialized medical assistance and allowing early detection and control of the introduction of arboviral diseases in Spain., Summary of the Results: The system was downloaded by 189 participants and used by 143 of them (76%). Median age was 38 years (IQR 16), and 134 (71%) were male. Mean duration of travel was 19 days (+/-9SD). During the Games the highest accumulated incidence observed was for headache: 6.06% cough: 5.30% and conjunctivitis: 3.03%. The incidence rate of cough during the Olympic Games was 1.1% per day per person, followed by headache 0.8% and 0.4% conjunctivitis or diarrhea. In our cohort we observed that non-athletes experienced more incidence of symptoms, except for incidence of cough which was the same in the two groups (1.1%). No participants reported symptoms fulfilling Zika definition case., Conclusion: Our system did not find cases fulfilling Zika definition amongst participants of the SOD during the Games, consistent with limited cases of Zika in Rio during the Games. The app showed good usability and the web based monitoring platform allowed to manage infectious cases in real-time. The overall system has proven to serve as a real-time surveillance platform for detecting symptoms that could be present in tropical imported diseases, especially arboviral diseases, contributing to the preparedness for the introduction of vector borne-diseases in non-endemic countries., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2018
- Full Text
- View/download PDF
11. Zika Virus Screening among Spanish Team Members After 2016 Rio de Janeiro, Brazil, Olympic Games.
- Author
-
Rodriguez-Valero N, Borobia AM, Lago M, Sánchez-Seco MP, de Ory F, Vázquez A, Pérez-Arellano JL, Rodríguez CC, Martínez MJ, Capón A, Cañas E, Salas-Coronas J, Galparsoro AA, and Muñoz J
- Subjects
- Anniversaries and Special Events, Athletes, Brazil, Disease Outbreaks prevention & control, Global Health, Humans, Risk Assessment, Spain, Sports, Travel, Zika Virus, Zika Virus Infection epidemiology, Zika Virus Infection virology
- Abstract
We evaluated the risk for the Spanish Olympic Team acquiring Zika virus in Rio de Janeiro, Brazil, during 2016. We recruited 117 team members, and all tested negative for Zika virus. Lack of cases in this cohort supports the minimum risk estimates made before the Games.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.